US Stock MarketDetailed Quotes

ORMP Oramed Pharmaceuticals

Watchlist

2.300
-0.010-0.43%

Close May 22 16:00 ET

93.45MMarket Cap8.85P/E (TTM)

Oramed Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

73.40%-1.48M

63.12%-10.3M

82.41%-1.42M

69.03%-694K

68.98%-2.63M

39.19%-5.55M

-151.02%-27.92M

-31.26%-8.06M

60.25%-2.24M

-161.31%-8.49M

Net income from continuing operations

142.48%1.53M

113.47%5.09M

252.20%13.3M

54.72%-3.28M

88.14%-1.31M

66.28%-3.61M

-208.15%-37.76M

-21.57%-8.74M

-28.94%-7.25M

-140.17%-11.07M

Operating gains losses

99.45%-7K

-39.16%-2.18M

79.21%-131K

-158.14%-1.59M

1,061.90%808K

-439.15%-1.27M

-4,497.06%-1.56M

-1,385.71%-630K

-62.86%-614K

-113.35%-84K

Depreciation and amortization

51.35%56K

237.93%196K

211.76%53K

260.00%54K

246.67%52K

236.36%37K

222.22%58K

-10.53%17K

-46.43%15K

Other non cash items

--21K

6,590.91%1.47M

--650K

----

--22K

----

Change In working capital

23.28%-626K

-185.90%-2.7M

70.88%-452K

-25.55%1.82M

-1,263.44%-3.25M

61.36%-816K

-34.91%-943K

-1,537.04%-1.55M

291.08%2.44M

-41.88%279K

-Change in prepaid assets

205.88%36K

217.91%852K

116.45%126K

-68.36%106K

-34.21%654K

88.47%-34K

158.26%268K

-629.52%-766K

181.91%335K

-3.68%994K

-Change in payables and accrued expense

-546.60%-666K

-491.76%-2.23M

-1,256.52%-624K

138.54%1.73M

-3,424.74%-3.23M

91.05%-103K

-154.57%-376K

-104.96%-46K

520.93%724K

-35.76%97K

-Change in other current liabilities

--0

105.26%2K

102.86%2K

-107.14%-5K

118.42%7K

---2K

-52.00%-38K

-94.44%-70K

537.50%70K

-2.70%-38K

-Change in other working capital

100.59%4K

-66.25%-1.33M

106.57%44K

-100.76%-10K

11.89%-682K

-1.65%-677K

11.74%-797K

1.33%-670K

292.80%1.31M

-16.22%-774K

Cash from discontinued investing activities

Operating cash flow

73.40%-1.48M

63.12%-10.3M

82.41%-1.42M

69.03%-694K

68.98%-2.63M

39.19%-5.55M

-151.02%-27.92M

-31.26%-8.06M

60.25%-2.24M

-161.31%-8.49M

Investing cash flow

Cash flow from continuing investing activities

327.21%30M

-341.76%-73.04M

166.40%30M

-6,212.45%-75.12M

-241.95%-14.71M

-279.41%-13.2M

130.44%30.21M

138.76%11.26M

-83.38%1.23M

413.08%10.36M

Net PPE purchase and sale

98.99%-2K

46.19%-254K

98.94%-3K

73.55%-32K

0.00%-20K

-323.40%-199K

-5,144.44%-472K

-951.85%-284K

-5,950.00%-121K

39.39%-20K

Net investment purchase and sale

330.70%30M

-337.23%-72.78M

159.85%30M

-5,662.22%-75.09M

-241.52%-14.69M

-275.59%-13M

130.92%30.68M

139.78%11.55M

-81.75%1.35M

416.66%10.38M

Net other investing changes

----

--2K

---1K

--0

----

Cash from discontinued investing activities

Investing cash flow

327.21%30M

-341.76%-73.04M

166.40%30M

-6,212.45%-75.12M

-241.95%-14.71M

-279.41%-13.2M

130.44%30.21M

138.76%11.26M

-83.38%1.23M

413.08%10.36M

Financing cash flow

Cash flow from continuing financing activities

-881.89%-19M

382.22%51.98M

-698.80%-25M

1,628.45%74.55M

6.02%2.43M

-82.20%10.78M

-92.41%4.18M

-80.27%4.31M

-100.00%-1K

Net issuance payments of debt

---19M

--49.55M

---25M

----

--0

----

Net common stock issuance

--0

-78.89%2.43M

--0

-100.05%-2K

--0

-18.15%2.43M

-80.81%11.5M

-89.31%4.16M

-76.79%4.38M

-100.00%-1K

Proceeds from stock option exercised by employees

----

--0

----

-90.30%62K

-99.86%20K

----

Net other financing activities

----

---783K

--0

---106K

--0

Cash from discontinued financing activities

Financing cash flow

-881.89%-19M

382.22%51.98M

-698.80%-25M

1,628.45%74.55M

--0

6.02%2.43M

-82.20%10.78M

-92.41%4.18M

-80.27%4.31M

-100.00%-1K

Net cash flow

Beginning cash position

-77.62%9.06M

47.38%40.46M

-83.53%5.47M

-77.36%6.77M

-13.81%24.1M

47.38%40.46M

-64.46%27.46M

-42.18%33.2M

-11.58%29.89M

87.31%27.97M

Current changes in cash

158.34%9.52M

-339.86%-31.36M

-51.46%3.58M

-138.41%-1.27M

-1,026.50%-17.34M

-3,203.04%-16.32M

126.25%13.07M

-62.83%7.37M

-86.02%3.3M

-90.08%1.87M

Effect of exchange rate changes

97.37%-1K

15.63%-54K

107.62%8K

-1,133.33%-31K

-86.79%7K

-153.33%-38K

-811.11%-64K

-3,400.00%-105K

200.00%3K

783.33%53K

End cash Position

-22.93%18.58M

-77.62%9.06M

-83.53%5.47M

-77.36%6.77M

-13.81%24.1M

47.38%40.46M

-47.62%40.46M

-42.18%33.2M

-11.58%29.89M

Free cash flow

74.29%-1.48M

62.87%-10.55M

83.02%-1.42M

69.26%-726K

68.81%-2.65M

37.33%-5.75M

-155.27%-28.41M

-35.68%-8.37M

58.12%-2.36M

-159.29%-8.51M

Currency Unit

USD

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	73.40%-1.48M	63.12%-10.3M	82.41%-1.42M	69.03%-694K	68.98%-2.63M	39.19%-5.55M	-151.02%-27.92M	-31.26%-8.06M	60.25%-2.24M	-161.31%-8.49M
Net income from continuing operations	142.48%1.53M	113.47%5.09M	252.20%13.3M	54.72%-3.28M	88.14%-1.31M	66.28%-3.61M	-208.15%-37.76M	-21.57%-8.74M	-28.94%-7.25M	-140.17%-11.07M
Operating gains losses	99.45%-7K	-39.16%-2.18M	79.21%-131K	-158.14%-1.59M	1,061.90%808K	-439.15%-1.27M	-4,497.06%-1.56M	-1,385.71%-630K	-62.86%-614K	-113.35%-84K
Depreciation and amortization	51.35%56K	237.93%196K	211.76%53K	260.00%54K	246.67%52K	236.36%37K	222.22%58K	-10.53%17K	-46.43%15K	-46.43%15K
Other non cash items	--21K	6,590.91%1.47M	--650K	----	----	----	--22K	----	----	----
Change In working capital	23.28%-626K	-185.90%-2.7M	70.88%-452K	-25.55%1.82M	-1,263.44%-3.25M	61.36%-816K	-34.91%-943K	-1,537.04%-1.55M	291.08%2.44M	-41.88%279K
-Change in prepaid assets	205.88%36K	217.91%852K	116.45%126K	-68.36%106K	-34.21%654K	88.47%-34K	158.26%268K	-629.52%-766K	181.91%335K	-3.68%994K
-Change in payables and accrued expense	-546.60%-666K	-491.76%-2.23M	-1,256.52%-624K	138.54%1.73M	-3,424.74%-3.23M	91.05%-103K	-154.57%-376K	-104.96%-46K	520.93%724K	-35.76%97K
-Change in other current liabilities	--0	105.26%2K	102.86%2K	-107.14%-5K	118.42%7K	---2K	-52.00%-38K	-94.44%-70K	537.50%70K	-2.70%-38K
-Change in other working capital	100.59%4K	-66.25%-1.33M	106.57%44K	-100.76%-10K	11.89%-682K	-1.65%-677K	11.74%-797K	1.33%-670K	292.80%1.31M	-16.22%-774K
Cash from discontinued investing activities
Operating cash flow	73.40%-1.48M	63.12%-10.3M	82.41%-1.42M	69.03%-694K	68.98%-2.63M	39.19%-5.55M	-151.02%-27.92M	-31.26%-8.06M	60.25%-2.24M	-161.31%-8.49M
Investing cash flow
Cash flow from continuing investing activities	327.21%30M	-341.76%-73.04M	166.40%30M	-6,212.45%-75.12M	-241.95%-14.71M	-279.41%-13.2M	130.44%30.21M	138.76%11.26M	-83.38%1.23M	413.08%10.36M
Net PPE purchase and sale	98.99%-2K	46.19%-254K	98.94%-3K	73.55%-32K	0.00%-20K	-323.40%-199K	-5,144.44%-472K	-951.85%-284K	-5,950.00%-121K	39.39%-20K
Net investment purchase and sale	330.70%30M	-337.23%-72.78M	159.85%30M	-5,662.22%-75.09M	-241.52%-14.69M	-275.59%-13M	130.92%30.68M	139.78%11.55M	-81.75%1.35M	416.66%10.38M
Net other investing changes	----	----	----	----	----	----	--2K	---1K	--0	----
Cash from discontinued investing activities
Investing cash flow	327.21%30M	-341.76%-73.04M	166.40%30M	-6,212.45%-75.12M	-241.95%-14.71M	-279.41%-13.2M	130.44%30.21M	138.76%11.26M	-83.38%1.23M	413.08%10.36M
Financing cash flow
Cash flow from continuing financing activities	-881.89%-19M	382.22%51.98M	-698.80%-25M	1,628.45%74.55M	0	6.02%2.43M	-82.20%10.78M	-92.41%4.18M	-80.27%4.31M	-100.00%-1K
Net issuance payments of debt	---19M	--49.55M	---25M	----	----	--0	--0	--0	----	----
Net common stock issuance	--0	-78.89%2.43M	--0	-100.05%-2K	--0	-18.15%2.43M	-80.81%11.5M	-89.31%4.16M	-76.79%4.38M	-100.00%-1K
Proceeds from stock option exercised by employees	----	--0	--0	----	----	----	-90.30%62K	-99.86%20K	----	----
Net other financing activities	----	----	----	----	----	----	---783K	--0	---106K	--0
Cash from discontinued financing activities
Financing cash flow	-881.89%-19M	382.22%51.98M	-698.80%-25M	1,628.45%74.55M	--0	6.02%2.43M	-82.20%10.78M	-92.41%4.18M	-80.27%4.31M	-100.00%-1K
Net cash flow
Beginning cash position	-77.62%9.06M	47.38%40.46M	-83.53%5.47M	-77.36%6.77M	-13.81%24.1M	47.38%40.46M	-64.46%27.46M	-42.18%33.2M	-11.58%29.89M	87.31%27.97M
Current changes in cash	158.34%9.52M	-339.86%-31.36M	-51.46%3.58M	-138.41%-1.27M	-1,026.50%-17.34M	-3,203.04%-16.32M	126.25%13.07M	-62.83%7.37M	-86.02%3.3M	-90.08%1.87M
Effect of exchange rate changes	97.37%-1K	15.63%-54K	107.62%8K	-1,133.33%-31K	-86.79%7K	-153.33%-38K	-811.11%-64K	-3,400.00%-105K	200.00%3K	783.33%53K
End cash Position	-22.93%18.58M	-77.62%9.06M	-77.62%9.06M	-83.53%5.47M	-77.36%6.77M	-13.81%24.1M	47.38%40.46M	-47.62%40.46M	-42.18%33.2M	-11.58%29.89M
Free cash flow	74.29%-1.48M	62.87%-10.55M	83.02%-1.42M	69.26%-726K	68.81%-2.65M	37.33%-5.75M	-155.27%-28.41M	-35.68%-8.37M	58.12%-2.36M	-159.29%-8.51M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall